Strut Health Review

Strut is a real and reasonably established business: Dallas-based, founded by Simal Patel, MD, operating before the GLP-1 gold rush, using US-licensed physicians and US compounding pharmacies. Nobody should read this review as suggesting it is a scam.

The concern is the compliance and service record. The FDA warning letter of 20 February 2026is a matter of public record and concerns misleading claims about the compounded GLP-1 products themselves. On the BBB, Strut is not accredited and carries a D+ rating— the lowest we have recorded for any provider on this site. Reported Trustpilot feedback averages around 3.2 across 700+ reviews; that figure and the BBB grade come from third-party summaries we could not verify directly, though multiple independent sources agree on both.

What to check before you buy

• •Read FDA warning letter 721448 (20 February 2026) yourself before purchasing
• •Get the standard, non-auto-refill price and the price at your target dose in writing
• •Ask which compounding pharmacy fills your order — Strut is not the compounder
• •Ask for bioavailability data if you are considering an oral lozenge, and weigh the injectable instead
• •Document your cancellation request in writing — cancellation friction is the top complaint theme
• •Confirm whether HSA/FSA payment is accepted before assuming a tax-advantaged offset

Did Strut Health get an FDA warning letter?

Yes. The FDA issued a warning letter to Strut Health, LLC dba Strut on 20 February 2026, reference number 721448. The FDA reviewed Strut's website in December 2025 and concluded that claims on the site concerning its compounded semaglutide and tirzepatide products were false or misleading, in violation of sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act — meaning the products were misbranded and were introduced into interstate commerce in violation of section 301(a). You can read the letter yourself on the FDA's warning letter database by searching that reference number. This is a formal regulatory action about the marketing of the exact products a reader of this page would be buying, which is why it leads our review.

How much does Strut Health cost?

Checked on 29 July 2026, Strut advertises oral semaglutide starting at $99/month, injectable semaglutide from $149/month, and both oral and injectable tirzepatide from $199/month. Its PeptideVite 'GLP-1 support' supplement is $46.99 for a 60-day supply. The important catch is that every one of those figures is the auto-refill subscription rate — the page shows savings of 13–21% against a standard price it does not display. Third-party reviews have reported substantially higher real-world monthly costs at higher doses. Get your actual price, at your actual dose, in writing before subscribing.

What is the 'medical necessity' requirement?

Strut states on its own weight-loss pages that semaglutide and tirzepatide are 'available for patients that fail or cannot use commercially available GLP-1 medications.' That reflects the current regulatory position rather than a marketing quirk. Tirzepatide came off the FDA shortage list in December 2024 and semaglutide in February 2025, and once a drug is no longer in shortage, pharmacies may not routinely compound what are essentially copies of the commercial product. Patient-specific compounding for a documented clinical need remains lawful. Strut stating this requirement openly is, to be fair, more compliant than platforms that still sell compounded GLP-1s as though nothing changed.

Are oral compounded GLP-1 lozenges as effective as injections?

There is no good evidence that they are, and you should treat this as the weakest link in the offering. The FDA-approved oral semaglutide product (Rybelsus) is a specific tablet formulation with an absorption enhancer, studied in trials at defined doses. A compounded sublingual or buccal lozenge is not that product, has not been through those trials, and has no published bioavailability data you can check. The FDA has specifically stated it has not identified a basis to conclude that the approved oral and injectable routes are medically unsuitable in a way a compounded buccal or sublingual product would address. If cost is what draws you to the lozenge, understand you are paying less for something with materially less evidence behind it.

Is Strut Health legitimate?

It is a real, established business — Dallas-based, founded by Simal Patel, MD, operating well before the GLP-1 boom, using US-licensed physicians and US compounding pharmacies. Legitimacy is not the question. The question is regulatory and service track record, and both give pause: an active FDA warning letter over misleading claims, a BBB profile that is not accredited and carries a D+ rating, and a reported Trustpilot average around 3.2 across 700+ reviews. Complaint themes are cancellation friction, unexpected cost increases and fulfilment delays rather than medication quality.

Is PeptideVite worth buying?

PeptideVite is sold as a 'GLP-1 support' supplement at $46.99 for 60 days. Be clear about what that is: a dietary supplement, not a medication, and not something with the regulatory review or trial evidence behind an approved drug. Supplements marketed as supporting or mimicking GLP-1 effects are not equivalent to GLP-1 receptor agonists and should not be treated as an alternative to prescribed treatment. If you are considering it alongside a prescription, tell your prescriber what is in it.

Where is Strut Health not available?

This offer is not available in Alaska. Strut serves the United States only. Prescribing is subject to physician review and the medical-necessity requirement, so approval is not guaranteed.